Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Acceptability, and Outcomes of the "RESPONSE-2" Program in Reducing Sedentary Behavior in Patients With Peripheral Arterial Disease: A Mixed Methods Pilot Study

NCT05961943 is registered in ClinicalTrials.gov with National Institute for Prevention and Cardiovascular Health, Ireland as lead sponsor.

NCT NCT05961943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05961943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Acceptability, and Outcomes of the "RESPONSE-2" Program in Reducing Sedentary Behavior in Patients With Peripheral Arterial Disease: A Mixed Methods Pilot Study
Lead sponsor
National Institute for Prevention and Cardiovascular Health, Ireland
Phase
Not applicable
Overall status
Unknown status
Start date
September 29, 2023
Completion date
August 31, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral arterial occlusive disease, sedentary behavior, sedentary time